141 related articles for article (PubMed ID: 35419102)
1. Quantitative CK19 biomarker detection in breast cancer cell lines.
Orafa Z; Karimi N; Keyvani S; Oloomi M
J Med Life; 2022 Feb; 15(2):188-195. PubMed ID: 35419102
[TBL] [Abstract][Full Text] [Related]
2. Assessment of Cytokeratin-19 Gene Expression in Peripheral Blood of Breast Cancer Patients and Breast Cancer Cell Lines.
Keyvani S; Karimi N; Orafa Z; Bouzari S; Oloomi M
Biomark Cancer; 2016; 8():57-63. PubMed ID: 27147896
[TBL] [Abstract][Full Text] [Related]
3. TAAR1 levels and sub-cellular distribution are cell line but not breast cancer subtype specific.
Pitts MS; McShane JN; Hoener MC; Christian SL; Berry MD
Histochem Cell Biol; 2019 Aug; 152(2):155-166. PubMed ID: 31111198
[TBL] [Abstract][Full Text] [Related]
4. Gene expression of cytokeratin 19 and its molecular detection in human breast cancer cell lines.
Uawisetwathana U; Rodpai E; Moongkarndi P
J Pharm Biomed Anal; 2016 Feb; 120():25-31. PubMed ID: 26690255
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometry: a new approach for the molecular profiling of breast cancer.
Lostumbo A; Mehta D; Setty S; Nunez R
Exp Mol Pathol; 2006 Feb; 80(1):46-53. PubMed ID: 16271361
[TBL] [Abstract][Full Text] [Related]
6. Preparation and
Okarvi SM; Aljammaz I
Anticancer Res; 2018 May; 38(5):2823-2830. PubMed ID: 29715105
[TBL] [Abstract][Full Text] [Related]
7. Comparative EPR Studies on the Influence of Genistein on Free Radicals in Non-Irradiated and UV-Irradiated MCF7, T47D and MDA-MB-231 Breast Cancer Cells.
Jurzak M; Ramos P; Pilawa B; Bednarek IA
Biomedicines; 2024 Feb; 12(3):. PubMed ID: 38540131
[TBL] [Abstract][Full Text] [Related]
8. Cytokeratin19-2g2, a novel fragment of cytokeratin19 in serum, indicating a more invasive behavior and worse prognosis in breast cancer patients.
Kong Y; Wang J; Liu W; Chen Q; Yang J; Wei W; Wu M; Yang L; Xie X; Lv N; Guo J; Li L; Gao J; Xie X; Dai S
PLoS One; 2013; 8(2):e57092. PubMed ID: 23468917
[TBL] [Abstract][Full Text] [Related]
9. An Effect of Culture Media on Epithelial Differentiation Markers in Breast Cancer Cell Lines MCF7, MDA-MB-436 and SkBr3.
Pirsko V; Cakstina I; Priedite M; Dortane R; Feldmane L; Nakazawa-Miklasevica M; Daneberga Z; Gardovskis J; Miklasevics E
Medicina (Kaunas); 2018 Mar; 54(2):. PubMed ID: 30344242
[No Abstract] [Full Text] [Related]
10. A targeted RNAi screen of the breast cancer genome identifies KIF14 and TLN1 as genes that modulate docetaxel chemosensitivity in triple-negative breast cancer.
Singel SM; Cornelius C; Batten K; Fasciani G; Wright WE; Lum L; Shay JW
Clin Cancer Res; 2013 Apr; 19(8):2061-70. PubMed ID: 23479679
[TBL] [Abstract][Full Text] [Related]
11. RERG (Ras-like, oestrogen-regulated, growth-inhibitor) expression in breast cancer: a marker of ER-positive luminal-like subtype.
Habashy HO; Powe DG; Glaab E; Ball G; Spiteri I; Krasnogor N; Garibaldi JM; Rakha EA; Green AR; Caldas C; Ellis IO
Breast Cancer Res Treat; 2011 Jul; 128(2):315-26. PubMed ID: 20697807
[TBL] [Abstract][Full Text] [Related]
12. Expression profiling of RTL1 in human breast cancer tissues and cell lines.
Mahmoudi AR; Ghods R; Madjd Z; Abolhasani M; Saeednejad Zanjani L; Safaei M; Balaei Goli L; Vafaei S; Katouzian L; Soltanghoraei H; Shekarabi M; Zarnani AH
Exp Mol Pathol; 2021 Aug; 121():104654. PubMed ID: 34087231
[TBL] [Abstract][Full Text] [Related]
13. Subtype-specific accumulation of intracellular zinc pools is associated with the malignant phenotype in breast cancer.
Chandler P; Kochupurakkal BS; Alam S; Richardson AL; Soybel DI; Kelleher SL
Mol Cancer; 2016 Jan; 15():2. PubMed ID: 26728511
[TBL] [Abstract][Full Text] [Related]
14. Differences and homologies of chromosomal alterations within and between breast cancer cell lines: a clustering analysis.
Rondón-Lagos M; Verdun Di Cantogno L; Marchiò C; Rangel N; Payan-Gomez C; Gugliotta P; Botta C; Bussolati G; Ramírez-Clavijo SR; Pasini B; Sapino A
Mol Cytogenet; 2014 Jan; 7(1):8. PubMed ID: 24456987
[TBL] [Abstract][Full Text] [Related]
15. Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer.
Evangelista AF; Oliveira RJ; O Silva VA; D C Vieira RA; Reis RM; C Marques MM
BMC Cancer; 2021 Jan; 21(1):76. PubMed ID: 33461524
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of cytokeratin 19 and OCT4 as survival markers in non-metastatic and metastatic breast cancer patients.
Abdelaziz LA; Ebian HF; Harb OA; Nosery Y; Taha HF; Nawar N
Contemp Oncol (Pozn); 2022; 26(1):78-87. PubMed ID: 35506041
[TBL] [Abstract][Full Text] [Related]
17. Transcriptome analysis of the cancer/testis genes, DAZ1, AURKC, and TEX101, in breast tumors and six breast cancer cell lines.
Mobasheri MB; Shirkoohi R; Zendehdel K; Jahanzad I; Talebi S; Afsharpad M; Modarressi MH
Tumour Biol; 2015 Sep; 36(10):8201-6. PubMed ID: 25994570
[TBL] [Abstract][Full Text] [Related]
18. Association of CD44
Chekhun VF; Lukianova NY; Chekhun SV; Bezdieniezhnykh NO; Zadvorniy TV; Borikun TV; Polishchuk LZ; Klyusov OМ
Exp Oncol; 2017 Sep; 39(3):203-211. PubMed ID: 28967645
[TBL] [Abstract][Full Text] [Related]
19. Cytokeratin 19 regulates endoplasmic reticulum stress and inhibits ERp29 expression via p38 MAPK/XBP-1 signaling in breast cancer cells.
Bambang IF; Lu D; Li H; Chiu LL; Lau QC; Koay E; Zhang D
Exp Cell Res; 2009 Jul; 315(11):1964-74. PubMed ID: 19265690
[TBL] [Abstract][Full Text] [Related]
20. Modulation of Molecular Biomarker Expression in Response to Chemotherapy in Invasive Ductal Carcinoma.
Oloomi M; Moazzezy N; Bouzari S
Biomed Res Int; 2018; 2018():7154708. PubMed ID: 29619374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
